Notre Dame d'Oe, France

Franck Biet


 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Franck Biet: Innovator in Antigenic Tripeptides

Introduction

Franck Biet is a notable inventor based in Notre Dame d'Oe, France. He has made significant contributions to the field of biotechnology, particularly in the development of antigenic tripeptides. With a total of 4 patents to his name, Biet's work has implications for detecting infections in animals.

Latest Patents

One of Franck Biet's latest patents is focused on antigenic tripeptides derived from subsp. S-type strains. This invention involves an isolated synthetic tripeptide of the formula H-D-Phe-N-Methyl-L-Val-L-Ala-OMe (SEQ ID NO: 1), or a derivative thereof. The corresponding lipotripeptides are specific to the subsp. (Map) S-type strain, along with their derivatives and conjugates. The invention also addresses the use of these antigens in various methods and tests for detecting Map infection, particularly by assessing the humoral and cell-mediated responses of infected animals. Additionally, it includes a genetic signature of Map and signatures for its presence or infection through mass spectrometry and NMR spectroscopy.

Career Highlights

Throughout his career, Franck Biet has worked with prestigious organizations, including the Institut Pasteur and the United States of America, as represented by the Secretary of Agriculture. His innovative work has positioned him as a key figure in the field of infectious disease research.

Collaborations

Franck Biet has collaborated with notable colleagues such as Sylvie Bay and John P Bannantine. These partnerships have further enhanced his research and contributions to the scientific community.

Conclusion

Franck Biet's work in the development of antigenic tripeptides showcases his innovative spirit and dedication to advancing biotechnology. His patents and collaborations reflect his commitment to improving methods for detecting infections in animals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…